Parasitology · 1993 · 109 citations · 6 references
MedicineInfectious DiseasesPharmacologyImmunopathologyImmunopharmacologyInnate ImmunityAntiparasitic AgentsAntiparasitic TherapyIn Vitro PharmacologyParasitic Disease PathogenesisProtozoan Host-parasite InteractionsProtozoan PathogenesisAntileishmanial ChemotherapyAntileishmanial TreatmentImmunopathology Of LeishmaniasisLeishmaniasis Of The SkinLeishmaniasis PathogenesisLeishmaniasis PathologyMacrophage Responses To LeishmaniaTreatment Of Leishmaniasis
We have investigated the effect of qinghaosu (QHS, artemisinin) and its derivatives on Leishmania major replication in vitro and on the disease development in mice infected with L. major. Artemisinin is effective against promastigotes in vitro, with an ED50 (50% effective dose) at 7.5 x 10(-7) M. Both artemisinin and artemether are leishmanicidal for amastigotes in infected murine macrophages in vitro, with ED50 at 3 x 10(-5) M and 3 x 10(-6) M respectively. These compounds have no effect on the viability of macrophages or on the phytohaemaglutinin-induced proliferation of normal spleen cells, even at 10(-4) M. BALB/c mice infected in the footpad with L. major developed significantly smaller lesions and parasite loads when treated with the compounds. Intra-lesion injection of the compounds was the most effective route. The intramuscular and oral routes were also effective; however, intravenous injection with artesunate was not effective.
6
ANTIMALARIAL ACTIVITY OF MEFLOQUINE AND QINGHAOSU
Jingbo Jiang, Xing-Bo Guo, Guoqiao Li et al. · The Lancet · 1982 · 193 citations
M D Sadick, Richard M. Locksley, Christopher W. Tubbs et al. · The Journal of Immunology · 1986 · 168 citations
F Y Liew, A M Singleton, Enrìco Cillari et al. · The Journal of Immunology · 1985 · 48 citations